Rani Therapeutics (NASDAQ:RANI) said it plans to cut around 25% of its workforce as part of a restructuring effort intended to prioritize three drug programs and extend its cash runway. As part of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results